TC | 
Stat | 
Stk | 
Ins | 
Fil | 
+d | 
+w | 
+m | 
+q | 
+h | 
+y | 
avg | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 5 | 1 | 1 | 3 | 17 | 22 | 47 | 15 | 
| S | %wins | 40 | 40 | 60 | 0 | 0 | 0 | 23 | 
Filing Date | 
					T Date | 
					Ticker | 
					Issuer | Inc | 					Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/25/13 14:11  | 11/22/13  | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Pawlicki Raymond | MA | O | SVP,CIO | S.d | -1,152 | 288.00 | 33 | -4 | -31 | 9 | D | 165 | 91 | 19 | 35 | 20 | 19 | 21 | 16 | 4 | 3 | -2 | 20 | 8 | 7 | 
9/18/13 16:26  | 9/16/13  | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Pawlicki Raymond | MA | O | SVP,CIO | S.d | -952 | 238.03 | 33 | -4 | -31 | 9 | D | 145 | 57 | 37 | 14 | 8 | 16 | 7 | 3 | 1 | -1 | -2 | 11 | 43 | 34 | 
2/7/13 13:55  | 2/6/13  | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Pawlicki Raymond | MA | O | SVP,CIO | S.d | -1,656 | 165.55 | 33 | -10 | -57 | 8 | D | 145 | 32 | 11 | 15 | 8 | 13 | 7 | 2 | 0 | 3 | 7 | 31 | 35 | 87 | 
6/21/12 11:41  | 6/19/12  | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Pawlicki Raymond | MA | O | SVP,CIO | S.d | -1,430 | 143.00 | 33 | -10 | -57 | 8 | D | 188 | 45 | 30 | 19 | 8 | 9 | 8 | 2 | -3 | 0 | 0 | 9 | 6 | 40 | 
6/5/12 15:39  | 6/4/12  | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Pawlicki Raymond | MA | O | SVP,CIO | S | -135 | 126.45 | 33 | -1 | -12 | 8 | D | 173 | 39 | 12 | 10 | 4 | -4 | -1 | 0 | 1 | 1 | 11 | 12 | 16 | 69 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |